Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × daromun × Clear all

Phase

Status

Unknown 2 Recruiting 2 Not yet recruiting 2 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 449 Carboplatin 324 Nivolumab 306 Cyclophosphamide 292 Specimen Handling 262 Magnetic Resonance Spectroscopy 256 Cisplatin 255 Paclitaxel 248 Radiotherapy 231 Gemcitabine 188 Dexamethasone 182 Biopsy 178 durvalumab 173 atezolizumab 156 Doxorubicin 141 Lenalidomide 135 Ipilimumab 135 Rituximab 134 Docetaxel 133 Bevacizumab 132 Capecitabine 123 Radiation 121 Oxaliplatin 120 Etoposide 118 Radiosurgery 117 Fluorouracil 117 Pemetrexed 110 fludarabine 106 venetoclax 102 Prednisone 100

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02938299 2024-09-19

Pivotal

Philogen S.p.A.

Phase 3 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡